fda warning letters compounded semaglutide telehealth 2024 2025 Dr. Elizabeth Kazarian, MD | Evidence based doctors never prescribed GLP1. The rest of you are catching up. Feb 6 2026 : “Today, the U.S. Food and Drug How GLP-1s Broke Healthcare Distribution

Who is administering ita licensed physician or an anti-aging consultant

The formulation is prepared by adding the target weight percentage of a JNK inhibitor that has been micronized and gamma irradiated to the appropriate amount of medium chain triglyceride that has been sterilized via filtration

Whether used alone or with compounded semaglutide or compound tirzepatide, this peptide promises to be a central figure in the future of obesity management and research

At this stage, the primary goal is to allow the body to adjust to the medication and minimise gastrointestinal side effects

If results were minimal, redirect resources to approaches with better evidence